Click on image to view larger version.

Figure 2 Rates of major adverse cardiac events (MACE) in patients with intermediate lesions in studies in which intervention was deferred based on physiologic lesion assessment (fractional flow reserve 0.75) or intravascular ultrasound analysis (minimal cross-sectional area >4.0 mm²) (7–11) vs. the current pooled analysis of drug-eluting stent (DES)-treated patients from four randomized trials.